Category:
VIM: New Route, Same Destination
Author – Alexander Kallen, MD, MPH Medical Officer CDC’s Division of Healthcare Quality Promotion Last week my colleague Dr. Brandi Limbago addressed the issue of carbapenem-resistant Enterobacteriaceae (CRE) and specifically enzymes called KPCs and NDM-1s that are causing the bacteria to become resistant to last-resort antibiotics. Today, CDC released a report about another enzyme causing Read More >
Posted on by 4 CommentsNDM-1: New Route, Same Destination – Untreatable Infections
Author – Brandi Limbago, PhD CDC’s Division of Healthcare Quality Promotion You’ve likely seen the news over the last couple of weeks warning people about “The [so-called] New Superbug NDM-1,” a newly discovered gene that makes bacteria resistant to last-resort antibiotics called beta-lactams or carbapenems. NDM stands for New Delhi Metallo-beta-lactamase, and in this case Read More >
Posted on by 16 CommentsSharing Successes and Challenges of Preventing CLABSIs in Dialysis
Author – Barbara Bond, RN Senior Quality Improvement Advisor Delmarva Foundation Each year, healthcare-associated infections (HAIs) cause substantial illness, hospitalization and, even, death in hemodialysis patients. From 1994 to 2007, rates of hospitalization for infection among this patient population have increased by nearly 38%. As infection rates have increased, so has our need to respond Read More >
Posted on by 5 Comments